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Purpose
Longitudinal studies support that symptomatic remission from Borderline Personality Disorder (BPD) is common, but recovery from the disorder probably involves a broader set of
changes in psychosocial function over and above symptom relief. A systematic review of literature on both symptomatic and personal recovery from BPD was conducted including the
views of consumers, clinicians, family and carers.

Materials and Methods
A PRISMA guided systematic search identified research examining the process of recovery
from BPD. Longitudinal studies with a follow-up period of five or more years were included
to avoid treatment effects.

Results
There were 19 studies, representing 11 unique cohorts (1,122 consumers) meeting the review
criteria. There was a limited focus on personal recovery and the views of family and carers
were absent from the literature. Rates of remission and recovery differ depending upon individual and methodological differences between studies. Data on symptomatic remission, recurrence and diagnosis retainment suggests that BPD is a stable condition, where symptomatic
remission is possible and the likelihood of recurrence following a period of remission is low.

Conclusion
Symptomatic remission from BPD is common. However, recovery including capacities such
as engaging in meaningful work was seldom described. Future research needs broader
measures of recovery as a sub-syndromal experience, monitoring consumer engagement
in meaningful vocation and relationships, with or without the limitations of BPD.
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Introduction
Since the deinstitutionalisation of mental health services and the rise of the consumer movement, differences in the conceptualisation of recovery have been proposed in the literature[1,
2]. Recent recovery frameworks have adopted a dimensional approach where, the clearest
divide between dimensions has been associated with clinical and personal notions of recovery
[3, 4]. Traditional notions of recovery have been clinically based, focused upon the remission
of symptoms (or no longer meeting diagnostic criteria) and the return to previous levels of
functioning[3–5]. Although Borderline Personality Disorder (BPD) has historically been
viewed as an untreatable disorder, more recent longitudinal studies have suggested an upward
trend towards remission[6–8] and improvements in levels of functioning[7, 9]. The definitions
for remission and reccurence in the literature were similar with high concordance, as they were
determined by diagnostic criteria and interview measures. The predominant definition used
for remision was no longer meeting the specified criteria for BPD and for recurrence was meeting diagnostic criteria following a period of achieving remission.
An increasing number of psychotherapeutic interventions have been developed specifically
for the treatment of BPD. Concerns have been raised over the insufficient evidence available to
demonstrate the broader efficacy of these interventions beyond symptom change[10–12]. Randomised control trials comparing identifiably different manualised treatments for BPD have
found similarities in the rates of improvement despite purported differences in approach[13].
Given that psychotherapy is the recommended first line intervention for the treatment of BPD,
strengthening interventions may improve consumer outcomes[14, 15].
Measuring functional outcomes and symptom remission is important, yet these measurements do not always take into consideration the broader views or lived experiences of consumers or differences in trajectory between individuals. Traditionally in the mental health
literature, consumers have challenged this clinical conceptualisation in favour of a holistic view
of mental health. ‘Personal recovery’ (or consumer driven definitions of ‘recovery’) has been
widely described within the literature (see [3, 4, 16, 17]). This review adopts the definition
most widely accepted within the recovery literature. Personal recovery is defined as ‘a deeply
personal, unique process of changing one’s attitudes, values, feelings, goals, skills, and/or roles.
It is a way of living a satisfying, hopeful, and contributing life even with limitations caused by
illness’ ([16, p527], Given that most clinical trials are only focused on symptom improvement,
and reviews of this literature are available, we chose to review studies that have taken a longer
perspective (five years or greater) on the journey of people with BPD. In this way we have
ensured that we focus our review on longer term outcomes where notions of recovery are likely
to become more important.
The lived experience of consumers diagnosed with BPD has attracted some attention in the
literature, where research has discussed the impact of the BPD diagnosis[18–20], the stigmatised nature of the disorder[19–21], experiences with treatment[21–24], and consumers’ experiences of the disorder[18, 25, 26]. There is no review examining the longer term outcomes of
people with BPD. The present study aims to systematically review the literature on longer-term
clinical and personal recovery from BPD through the perspectives of consumers, clinicians,
family and carers. A comparison between recovery in BPD compared to other mental health
disorders will also be explored. Through this, gaps in the literature and future research directions will be identified.

Materials and Methods
The review followed the Preferred Reporting Items for Systematic Review and Meta-Analysis
(PRISMA) statement[27] in reporting findings of the review (See S1 Table). A predetermined

PLOS ONE | DOI:10.1371/journal.pone.0160515 August 9, 2016

2 / 21

Recovery from Borderline Personality Disorder

protocol outlining methods of data searching, inclusion criteria and data extraction method
used was registered on the International Prospective Register of Systematic Reviews (PROSPERO, registration number: CRD42015019838).
Articles included for review were identified using a three step process: 1) searching electronic databases, 2) reference list searching and 3) identifying articles known to researchers
which complied with the inclusion criteria. Electronic databases searched included; PsychINFO, Psychological and Behavioural Collection, PubMed, Scopus and Web of Science. The
same search strategy was used in all databases and included; [(Consumer OR Client OR Patient
OR Service User) AND/OR (Clinician OR Therapist) AND/OR (Family OR Carer OR Significant Other)] AND [(Borderline Personality Disorder OR BPD) AND (Qualitative OR Longitudinal) AND (Remission OR Recovery OR Hope OR Psychotherapy OR Therapy OR Client
Cent OR Resilience OR Social Support OR Social Inclusion OR Wellbeing OR Rehabilitation
OR Meaning)]. Searches were limited to articles published in English and to research conducted with humans.
Reference lists of sources included in the review were scanned to further identify additional
sources. This process was completed twice, firstly on sources identified from the initial electronic database search and secondly on articles identified from the first reference list search.
Known sources, particularly recently published articles not identified by the electronic search
or reference list search, which complied with the inclusion criteria, were included in the review.
One researcher conducted the search and identified articles for inclusion in the review. Articles
were initially assessed via their title and abstracts and then in full. Articles eligible for inclusion
in the review were checked with an expert in personality disorders. Disagreements were
resolved by consensus. One reviewer then extracted data from the included studies, which was
checked by a second reviewer. Location of the study, sample, aims, inclusion criteria, data collection methods and tools, major findings and limitations were extracted and coded. To reduce
the risk of bias, all articles included in the review were assessed for quality as described below.
Qualitative and longitudinal sources were assessed separately using quality assessment tools
specific to the methodology.
A predetermined inclusion and exclusion criteria was used to identify articles relevant to the
research question. All included studies were required to have BPD as the main disorder under
examination and be published in English. Where more than one disorder was examined in an
individual study, it was only included in the review if BPD was the main focus of investigation
and the other disorders acted as either a comparison group or control group. For example studies which examined the relationship between BPD and other personality disorders was
included in the review, so long as they met the other inclusion criteria. As the review aimed to
examine the long-term outcomes of BPD, the review was interested in the symptomatic remission and consumer understandings of recovery. All perspectives from consumers, families, carers or clinicians were included in the review to gain a holistic view of recovery. Studies were
included in the review if the participants described were within the community or inpatient settings at the time of data collection. This however, excludes all patients from the forensic system
with the BPD diagnosis, including consumers in forensic psychiatric inpatient units and their
carers and clinicians. This is due to the association between BPD and antisocial personality disorder which is prevalent within forensic settings and not the focus of the present review.
The mention of treatments received by patients within individual studies did not lead to its
exclusion, however studies that were conducted with intention to evaluate the effectiveness of
specific interventions or comparative treatment studies were excluded from the review. This
was due to the aim to examine the long-term outcomes of BPD rather than study treatment
effects or treatment trial implementation. Due to this treatment trials with a follow-up period
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of less than five years were also excluded. No restrictions were placed on the publication
period.
The quality of longitudinal studies was assessed using a criteria adapted from Kuijpers and
colleagues[28] and Luppino and colleagues’[29] review which evaluated domains including
study population, baseline and follow-up measures and the measurement tools used, and has
been widely used in previous research (for example [30, 31]). Items on the quality assessment
criteria were scored using a plus, minus or question mark. A score of one was given to items
rated as a plus and a score of zero was given to items rated as a minus or question mark (See S2
Table). Studies were required to score at least six out of ten quality criteria in order to be
included for review [28, 29]. Included studies scored highly on all domains assessed, however
common domains that studies did not fulfil included having less than 75% of the initial cohort
included in the study, having a dropout rate greater than 20% at follow-up, and diagnosing
study participants with BPD without a clinical interview.
Quality of qualitative studies was assessed using a combination of assessment tools which
examined credibility and rigour. The quality assessment criteria developed by Kuper, Lingard
and Levinson[32] assessed domains including the sample, data collection, analysis, transferability of results, ethical consideration and coherence of the study. Studies were ranked as ‘very
good’, ‘good’, ‘acceptable’ or ‘unclear’, where an ‘acceptable’ or above score in four of the six
domains was required in order to be included in the review. Qualitative studies were also
classed on the hierarchy of qualitative evidence[33], which ranged from single case studies
(least likely to produce good evidence for practice), descriptive studies, conceptual studies and
generalisable studies (strongest) (See S3 Table). These methods of appraising qualitative
research have been used in a number of studies[34–36]. All domains assessed from the
included qualitative articles was ranked ‘acceptable’ or higher, except in one domain in Lariviere and colleagues’[18] where it was unclear if ethical issues were considered.
A thematic synthesis approach adapted from Thomas and Harden[37] was used to identify
key themes from included studies. A three step process involving: 1) line by line inductive coding of the results section of included studies, 2) translation of codes into descriptive themes,
and 3) the development of analytical themes was used. Multiple codes were used to encapsulate
the meaning and content of findings in line by line coding. Descriptive themes were developed
through translating codes. The synthesis of descriptive themes to analytical themes was guided
by the research question of the review which incorporated the theoretical conceptualisations of
recovery. The trustworthiness of the data was ensured through consistent discussion amongst
the research team about emerging codes and themes, where discrepancies were resolved via
consensus.

Results
Search Results
A total 697 sources was identified through electronic database searching (n = 426) and identifying additional sources (n = 271). Following the application of limits (to the English language
and research conducted with humans) and the removal of duplicates, 514 sources were
screened through their title and abstract. A total of 479 sources were excluded from the review,
as they did not meet the inclusion criteria. Of the remaining 35 sources, 16 sources were
excluded due to sources not being empirical in nature (n = 1), not related to recovery or remission (n = 12), follow-up period in longitudinal studies was less than five years (n = 2) or the
methodology was not longitudinal or qualitative in nature (n = 1). The remaining 19 sources
were included for review, consisting of 16 longitudinal studies and three qualitative studies
(See Fig 1).
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Fig 1. PRISMA flowchart for the selection of studies included in the systematic review.
doi:10.1371/journal.pone.0160515.g001

Study Characteristics
Overview of quantitative studies. Of the 19 included studies, 16 studies were longitudinal
in nature (See Table 1). The range of publication years lead to differences in the method used
to assess patients for diagnosis of BPD where chart analysis (n = 9)[6, 7, 9, 38–43] and clinical
interviewing (n = 7)[8, 44–49] was used. Studies predominately used the Diagnostic and Statistical Manual of Mental Disorders—Third Edition criteria (DSM-III; n = 5) to determine the
inclusion of participants and in assessing remission, recurrence or diagnosis retainment status,
whilst others used the Diagnostic Interview for Borderlines (DIB; n = 4), DSM Fourth Edition
(DSM-IV; n = 1), DIB and DSM-III-R (n = 4) or the DSM-III and Gunderson and Kolb[50]
criteria (n = 2). Several measures of functioning were used depending on when the study was
conducted, these included the Health Sickness Rating Scale (HSRS; n = 4), the Global Assessment Scale (GAS; n = 4) and the Global Assessment of Functioning (GAF; n = 5) although
these are all highly similar. Three studies did not measure a participant’s level of functioning.
All quantitative studies met the quality appraisal criteria and all were included for review.
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Table 1. Characteristics of included studies.
Source Study type

Location

Sample

Aim

Inclusion criteria

Data collection and
measures used

Findings

Limitations

[6]

Longitudinal
(follow-up on
average 27
years)

Canada

Patients with BPD (n = 64)

To follow-up patients to
examine whether
symptomatic relapses
occur during later middle
age.

• Part of the pervious
follow-up phase[43]

• DIB-R
• SCID
• GAF
• SCL-90
• SAS-SR

Signiﬁcant decrease in the
prevalence of BPD and the
number of criteria still met
in the sample. No
signiﬁcant differences in
functioning over the
baseline and follow-up
period, however attributed
this to use of different
scales and it is proposed
that there is a limit on the
level of improvement in
patients with BPD.

Chart review was used
to identify patients
meeting criteria for BPD.

[7]

Longitudinal
(follow-up on
average 15
years,
range = 2–32)

United
States

Patients with BPD (n = 81),
Schizophrenia (n = 163)
and Unipolar affective
disorder (n = 44)

To examine the long term
course and outcomes of
individuals diagnosed with
BPD compared to patients
with schizophrenia or UNI.

• Patients discharged
from Chestnut Lodge
between 1950 and
1975. A select number
of non-discharged
patients were also
included
• Patients without
organic brain
syndrome
• Aged between 16
and 55 years
• Inpatient for a
minimum of 90 days

• Used chart
analysis to rediagnose patients
• BPD: (DSM-III
criteria, Gunderson
and Kolb [50].
• Schizophrenia:
(New Haven
Schizophrenia
Index, Feighner and
colleagues[52]
criteria, Research
Diagnostic Criteria)
• MDD and
Schizotypal PD:
(DSM-III criteria)

Diagnosis of BPD
remained stable over the
follow-up period. Use of
services was a similar rate
in consumers with BPD
and UNI but higher in
patients with
schizophrenia. Compared
to patients with UNI or
schizophrenia, patients
with BPD have better
levels of vocational
engagement, global
outcomes (hospitalisation
and symptoms
experienced). Full recovery
was perceived as
unachievable due to
chronicity of disorder and
individual character.

The study used chart
analysis to identify
potential patients,
however more than 20%
of participants dropped
out of the study at
follow-up. The study
does not discuss
treatments participants
have engaged in.

[8]

Longitudinal
(follow-up at 16
years)

United
States

Patients with BPD
(n = 231)

To determine the time
needed to reach and the
stability of symptomatic
remission and recovery in
patients with BPD

• Aged between 18–35
years
• IQ above 71
• No history of
schizophrenia,
schizoaffective
disorder, bipolar I or
organic conditions
• Fluent in English

• Semi-structured
interviews:
• Background
Information
Schedule
• Structured Clinical
Interview for
DSM-III-R Axis I
disorders
• Revised Diagnostic
Interview for
Borderlines
• Diagnostic
Interview for
DSM-III-R
Personality
Disorders

Symptomatic remission for
a two year period was
achieved by 99% of
participants. Compared to
other Axis II disorders,
BPD had a slower
remission rate. Recovery
occurred slowly and there
was a higher risk of relapse
compared to other
disorders. Vocational
participation impacted
upon obtaining recovery.

Patients were recruited
from an inpatient setting
which may inﬂuence
functioning scores and
may not be
representative of the
general population.
Difﬁculties with
comparing GAF scores
as scores at baseline
and follow-up were not
presented. The types of
treatment consumers
engaged in during the
follow-up period are
unclear.

[9]

Longitudinal
(follow-up on
average 13.6
years

United
States

Study draws from a larger
sample (N = 237) however,
reports on patients with
‘pure’ BPD (n = 43), BPD
and SPD (n = 6), BPD and
SDPD (n = 5), BPD and
MDD (n = 9),
schizophrenia (n = 19),
MDD (n = 24), SPD
(n = 13)

To examine the functioning
of patients with BPD or
SPD compared to
schizophrenia, MDD and
other disorders.

• Admitted to Austen
Riggs Center for at
least 2 months
between 1950 and
1976

• GAS

Patients with BPD had
better levels of functioning
than patients with
schizophrenia, however no
difference with patients
with MDD. BPD and MDD
group was found to be
functioning worse than
aggregated BPD group
which is inconsistent with
the previous literature.

Differences in sample
size between groups in
the study, reliability of
results is questionable.

[18]

Qualitative

Canada

12 female service users
from two BPD specialist
services in Quebec,
Canada.

To capture the recovery
experiences of women
from BPD through analysis
of experiences through the
PEO model.

• Participants had to
be female, diagnosed
with BPD, be aged
between 18 and 65
years and had
completed 2 years of
treatment for BPD in a
specialised service.

• Creation of a
picture collage, two
semi-structured
interviews and
review of medical
records.
• Thematic analysis
of semi-structured
interviews

Consumers associated
recovery with personal
development, greater
emotional control,
assertiveness,
interpersonal relationships,
having meaningful roles/
vocation and letting go of
the past and looking
towards the future. It is
suggested that the concept
of wellbeing may better
encapsulate the
experiences of consumers
than ‘recovery’.

Small sample size and
only included the
perspectives of female
consumers. Analysis
completed in line with
PEO model, may have
missed perspectives
that did not ﬁt within the
categories

(Continued)
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Table 1. (Continued)
Source Study type

Location

Sample

Aim

Inclusion criteria

Data collection and
measures used

Findings

Limitations

[22]

Qualitative

United
Kingdom

Consumers with BPD
(n = 48)

To gain understanding into
the goals and aspirations
of service users to better
understand views of
recovery

• Individuals that were
over 18 years of age,
diagnosis of BPD and
history of self-harm
(self–injurious
behaviour, overdose
or suicide attempts)

• Semi-structured
interviews
• Grounded theory
and thematic
analysis

Consumer recovery goals
were associated with
improving symptoms of
BPD and engaging in
meaningful activities.
However consumers did
not believe specialised
treatments for BPD
prioritised their goals. Level
of recovery ﬂuctuated
within participants where
most acknowledged that
they had improved but not
fully recovered. This led to
questions of whether
‘recovery’ encapsulated
their experience.

Limited to perspectives
of consumers. Study
conducted in one
location.

[38]

Longitudinal
(follow-up range:
4–7 years)

United
States

Patients with Borderline
Personality Disorder
(n = 33)

To examine the validity of
the BPD diagnosis and
compare BPD to DSM-III
schizophrenia, MDD and
other PDs.

• Inpatient at McLean
Hospital between
1974 and 1977
• Aged over 18 years
• Based on hospital
records received a
score of 6 or more on
the DIB
• Met DSM-III
diagnostic criteria for
BPD

• DSM-III
• DIB

Differences between
patients with BPD, BPD
and MDD and
schizophrenia were
identiﬁed. BPD and
schizophrenia diagnosis
was stable, however the
BPD diagnosis was less
stable in patients with BPD
and MDD. Comorbidity with
MDD predicted better
functioning and symptom
remission.

The study had a small
sample size and over
half of the sample also
met criteria for DSM-III
Major Affective Disorder.

[39]

Longitudinal
(follow-up
average 15 years
after discharge,
ranged between
2–32 years)

United
States

Patients with BPD (n = 81)

To identify outcome
predictor variables for BPD
and examine the
applicability of
schizophrenia predicator
variables for BPD.

• Without organic brain
syndrome
• Between 16 and 55
years at admission
• Treated at Chestnut
Lodge for at least 30
days

• Diagnosis
assigned through
transposition of
medical records to
the chart abstract.
• Based on 56
demographic/
predictor variables
and 49 signs and
symptom variables.
• Standard Followup Interview Battery
and Extended
Interview Follow-up
Battery (see [53])

Diagnosis of BPD
remained stable at followup with approximately 50%
of patients experiencing
moderate levels of
symptoms. Patients with
BPD accessed treatment
at the same rate as
patients with UNI but at a
lower rate than patients
with schizophrenia.
Patients with BPD were
more likely to be engaged
in vocation and had higher
global outcomes.

The study used chart
analysis to identify
potential patients,
however more than 20%
of participants dropped
out of the study at
follow-up. The study
does not discuss which
treatments participants
have engaged in.

[40]

Longitudinal
(follow-up on
average 13.6
years

United
States

Study draws from a larger
sample, however reports
on patients with BPD only
(n = 33)

To identify predictors of
outcome in BPD.

• Admitted to Austen
Riggs Center for at
least 2 months
between 1950 and
1976Minimal
comorbidities with
affective disorder,
substance abuse or
other PDs.

• GAS

Strongest predictors of
outcome in patients with
BPD were associated with
demographic variables.
Symptoms of personality
disorder were identiﬁed to
predict poorer social and
vocational prognosis at
follow-up. Poorer
vocational outcomes were
also predicted by
experiences of chronic
emptiness or boredom. Did
not ﬁnd the link between
higher IQ and better
outcomes.

Limited sample of
patients with BPD.

[41]

Longitudinal
(follow-up at 16
years)

United
States

Patients diagnosed with
BPD and schizophrenia

To describe the global
outcomes of patients with
BPD

• Admitted to the
General Clinical
Service at New York
State Psychiatric
Institute for at least 3
months

• Chart analysis
• DSM-III criteria
• Guidelines for BPD
by Kernberg[54]
• GAS

Patients with schizophrenia
were more likely
hospitalised during the
follow-up period compared
to patients with BPD,
similarly observed in rates
of institutionalised care
during follow-up. More
patients with BPD were
able to work at least 50% of
the follow-up, however
patients with schizophrenia
were identiﬁed as most
‘handicapped’.

Use of chart review to
diagnose patients. Does
not discuss remission,
recurrence or retainment
rates

(Continued)
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Table 1. (Continued)
Source Study type

Location

Sample

Aim

Inclusion criteria

Data collection and
measures used

Findings

Limitations

[42]

Longitudinal
(follow-up at 16
years)

United
States

Patients diagnosed with
BPD (n = 205)

To describe the global
outcomes of patients with
BPD

• Patients admitted
into New York State
Psychiatric Institute
between 1963–1976

• GAS

Consumers with BPD had
higher levels of functioning
and most reached a
‘clinically well’ stage
compared to patients with
schizophrenia. Patients
with comorbid MDD had
higher levels of functioning
than patients with BPD
only. Similar suicide rates
in BPD and schizophrenia
groups.

Baseline data on
functioning scores is not
provided and the types
of treatment received by
patients is not clear

[43]

Longitudinal
(follow-up for an
average of 15
years)

Canada

Patients with BPD
(n = 100)

To examine long term
outcomes of patients with
BPD being treated in a
general hospital

• Diagnosis of BPD or
retrospective
diagnosis of BPD

• DIB
• HSRS
• Schedule for
Follow-up of
Borderline Patients

Quarter of patients still met
criteria DIB for BPD.
Patients at follow-up was
functioning better however
still had some difﬁculties.
Work history, relationships
and family adjustment was
at a comparable level to
outpatients. Social
functioning improved due
to less chaotic
relationships, however
dysphoria, younger age at
diagnosis and family
history predicted worse
outcomes.

Chart review was used
to identify patients
meeting criteria for BPD.
No comparison score for
HSRS at baseline.
Unable to determine
signiﬁcance of change
at follow-up. Limited
patient demographic
information provided.
Effects of treatment
unclear from data.

[44]

Longitudinal (6
year follow-up)

United
States

Patients with BPD
(n = 290)

To examine the six year
course of syndromal and
sub-syndromal BPD.

• Aged between 18
and 35 years
• IQ of 71 or higher
• No history of an
organic condition,
schizophrenia,
schizoaffective
disorder or Bipolar I
Fluent in English

• SCID DIB-R
• Background
Information
Schedule

Remission from BPD was
common and increased
with every follow-up phase.
At two year follow-up,
34.5% of consumers had
achieved remission. Over
the six year period, 73.5%
of consumers had
experienced remission.
Only 5.9% of consumers
experienced recurrence.

Participants were
recruited from an
inpatient setting and
may not be
representative of the
general population.
Treatment engagement
is unclear.

[45]

Longitudinal
(follow-up at 7
years)

Canada

Patients with borderline
psychopathology (n = 88)
or traits (n = 44)

Aimed to examine the
relationship between
borderline
psychopathology and other
clinical disorders at followup

• Aged between 18
and 65 at admission
• Inpatient in acute
psychiatric setting
Clinical diagnosis of
BPD or at least 3 of 7
borderline
characteristics as
described by
Gunderson and Kolb
[50]

• SADS
• RDC
• DIB

At follow-up 47.4% of
patients retained the BPD
diagnosis. Persistent group
more likely to be diagnosed
with other clinical disorders
compared to the remitted
group, however no
differences in the number
of depressive episodes
between these groups
were identiﬁed. ‘New’ BPD
group had higher episodes
of depression. Borderline
psychopathology at
baseline was predictive of
other clinical disorders at
follow-up.

More than 20% of
participants dropped out
of the study which lead
to an over proportion of
females in the sample.
Types of treatment
received by participants
is unclear.

[46]

Longitudinal (10
year follow-up)

United
States

Three study groups; BPD
(n = 175), cluster C PD
(n = 312) and MDD (n = 95)

Compare course of BPD
(symptoms and
functioning) with other PDs
and MDD

• Participants had to
be 18–45 years old
who have received
psychiatric care and
met criteria of
screening tools
including PSQ,
DIPD-IV, PAF, SNAP

• DIPD
• DSM-IV
• GAF
• Same measures
used at baseline, 6
months and 12
months and 2,4,6,8
and 10 years.

Signiﬁcant proportion of
patients (91%) achieved
remission and relapse was
less common in BPD
compared to other
disorders. Patients with
BPD had poorer levels of
functioning compared to
patients with OPD and
MDD at follow-up. Older
age predicted poorer
functioning and higher
levels of education
predicted higher levels of
functioning. Engagement in
vocation and marital status
improves over time.

Study does not provide
information on the
treatments received by
consumers and does not
take into consideration
the views of consumers

(Continued)
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Table 1. (Continued)
Source Study type

Location

Sample

Aim

Inclusion criteria

Data collection and
measures used

Findings

Limitations

[47]

Longitudinal
(follow-up at 7
years)

Canada

Patients diagnosed with
Borderline Personality
Disorder (n = 88) and
patients with borderline
traits (n = 44)

Aimed to examine the
persistence of BPD and
occurrence of other
personality disorders at
follow-up. To identify the
predictive value of
personality disorder
psychopathology in
determining severity of
BPD and other PDs at
follow-up.

• Aged between 18
and 65 at admission
• Inpatient in acute
psychiatric setting
• Clinical diagnosis of
BPD or at least 3 of 7
borderline
characteristics as
described by
Gunderson and Kolb
[50]

• SADS
• RDC
• DIB
• GAS
• SIDP-R

At follow-up 47.4% of
patients retained BPD
diagnosis and patients with
persistent BPD had a
higher incidence of other
PDs. Persistent and ‘new’
groups had a similar
number of comorbid PDs.
DIB level of
psychopathology at
baseline was predictive of
borderline
psychopathology and selfdefeating behaviours at
follow-up.

More than 20% of
participants dropped out
of the study which lead
to an over proportion of
females in the sample.
Type of treatment
received by participants
is unclear.

[48]

Longitudinal
(based on 10
year follow-up
data)

United
States

Patients with BPD
(n = 249)

To determine which
variables best predict
remission from BPD

• Aged between 18–35
years
• IQ above 71
• No history of
schizophrenia,
schizoaffective
disorder, bipolar I or
organic conditions
• Fluent in English

• Semi-structured
interviews
• Background
Information
Schedule
• SCID
• DIB-R
• DIPD

The amount of time for
remission was found to be
predicted by younger age,
no prior hospitalisations, no
history of child sexual
abuse, low levels of verbal,
physical and emotional
abuse and limited
witnessing of violence.
Higher levels of childhood
competence and the
absence of family history of
mood or substance
disorder decreased the
time to remission. Not
having comorbidities with
PTSD or anxious cluster
personality disorders,
having normal personality
traits and a good
vocational record
decreased time to
remission.

Patients were recruited
from an inpatient setting
which may inﬂuence
functioning scores and
may not be
representative of the
general population.
Difﬁculties with
comparing GAF scores
as scores at baseline
and follow-up were not
presented. The types of
treatment consumers
engaged in during the
follow-up period were
unclear.

[49]

Longitudinal (10
year follow-up)

United
States

Patients with BPD
(n = 249)

Continuation of the
McLean Study of Adult
Development which aimed
to examine the rates of
symptom remission,
recovery and sustained
recovery in BPD.

• Aged between 18–35
years
• IQ above 71
• No history of
schizophrenia,
schizoaffective
disorder, bipolar I or
organic conditions
• Fluent in English

• Semi-structured
interviews:
• Background
Information
Schedule
• SCID
• DIB-R
• DIPD

Symptomatic remission
was achieved by the
majority of participants
(98%) where 86% of
participants were able to
maintain for a four year
period. Recovery was
identiﬁed to be more
difﬁcult to achieve,
however was table once
attained. Difﬁculties with
functioning still observed at
10 years.

Patients were recruited
from an inpatient setting
which may inﬂuence
functioning scores and
may not be
representative of the
general population. The
types of treatment
consumers engaged in
during the follow-up
period are not clear.

[51]

Qualitative

Norway

Thirteen female service
users

To identify how the
recovery process leads to
changes in suicidal
behaviour

• Participants had to
be female with a
diagnosis of BPD

Thematic analysis of
semi-structured
interviews

Recovery process
facilitated changes to
suicidal behaviours, by
increasing consumers’
desire to take responsibility
for self, being understood
and refusing to be defeated
by the disorder. Selfdevelopment assisted with
developing trust and a
sense of safety with self
and others.

Only the perspectives of
female consumers were
considered and the
study had a small
sample size

BPD, Borderline Personality Disorder; DIB, Diagnostic Interview for Borderlines; DIB-R, Revised Diagnostic Interview for Borderlines; DIPD-IV, Diagnostic
interview for DSM-IV Personality Disorders; DSM-III, Diagnostic and Statistical Manual for Mental Disorders–Third Edition; DSM-IV, Diagnostic and
Statistical Manual for Mental Disorders–Fourth Edition; GAF, Global Assessment of Functioning; GAS, Global Assessment Scale; HSRS, Health-Sickness
Rating Scale; IQ, Intelligence Quotient; MDD, Major Depressive Disorder; OPD, Other Personality Disorder; PAF, Personality Assessment Form; PD,
Personality Disorder; PEO, Person-Environment-Occupation; PSQ, Personality Screening Questionnaire; RDC, Research Diagnostic Criteria; SADS,
Schedule for Affective Disorders and Schizophrenia; SAS-SR, Social Adjustment Scale; SCID, Structured Clinical Interview for DSM-III-R Axis I Disordersl;
SCL-90, Symptom Check List-90; SDPD, Schizoid Personality Disorder; SIDP-R, Structured Interview for DSM-III-R Personality; SNAP, Schedule for Nonadaptive and Adaptive Personality; SPD, Schizotypal Personality Disorder.
doi:10.1371/journal.pone.0160515.t001
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Overview of qualitative studies. From the 19 included studies, three studies were qualitative in methodology[18, 22, 51], which aimed to gain an understanding of the recovery process
from BPD through the perspectives of consumers (See Table 1). Two studies were conducted
in Europe and the other in North America. All studies were conducted using semi-structured
interviews, however differed in analysis technique where one study analysed responses through
a grounded theory approach[24], whilst the remaining studies used thematic analysis[18, 51].
Articles represented different professional backgrounds including psychology, occupational
therapy and nursing. All qualitative studies were appraised using the Kuper, Lingard and Levison[32] guidelines and all were rated above the ‘acceptable’ standard. Studies were also ranked
using the Daly and colleagues[33] hierarchy of evidence were two studies were categorised as
conceptual studies[22, 51] indicating that theoretical frameworks guided the recruitment and
analysis of results which reflected participant’s views. The remaining study was categorised as a
descriptive study[18] where the article described the participant’s view in a practical rather
than theoretical manner. All studies met the minimum quality criteria and were included for
review.

Sample Characteristics
To avoid duplication of participants, longitudinal studies that had more than one published
follow-up article were not all included in the sample characteristics. In these cases, only the
baseline study of the specific cohort was counted. Overall, the 19 included studies represented
11 unique cohorts of participants (eight cohorts from included longitudinal studies and three
cohorts from included qualitative studies), equating to a total of 1122 individual consumers
with BPD. Consumers represented in the included studies were predominately female (72.5%)
from a Western background (84.6%) with an average age of 30.3 years. Most were never married (63%) and were not engaged in a vocation (64.9%).

Main findings from quantitative studies
The findings from the quantitative studies were categorised into three major themes: 1) remission, recurrence and diagnosis retainment rates, 2) level of functioning, 3) predictors of outcomes, and 4) differences between BPD and other disorders.
Remission, recurrence and diagnosis retainment rates. Definitions used to identify
remission, recurrence and diagnosis retainment rates were determined by the definitions used
by the included studies. As such remission rates represented patients who had previously met
the specific diagnostic criteria for BPD but did not meet criteria at follow-up. Similarly, recurrence refers to patients who had previously achieved a state of remission, however experience
symptoms meeting the diagnostic cut-off at follow-up. Diagnosis retainment was defined and
represented by patients who met diagnostic criteria during one follow-up wave and continued
to meet criteria at the next follow-up wave, thus retaining a diagnosis of BPD.
The follow-up period of studies discussing remission, recurrence, and diagnosis retainment
ranged between 4 and 27 years. Data on remission rates were available in five cohorts (representing nine studies)[6, 8, 38, 43–47, 49], where rates ranged between 33–99% of patients.
Table 2 shows the five studies and includes the follow-up timeframe the proportion in remission. Reccurence rates were avaliable for two cohorts (representing four studies)[8, 44, 46, 49],
ranging between 10–36% of patients,. Table 3 shows the recurrence rates and follow-up duration. Retainment rates were available for four cohorts (representing six studies)[6, 38, 43, 45–
47] ranging between 7.8–66.7% of patients as shown in Table 4.
Level of functioning. Most longitudinal studies examined the level of functioning of
patients within their cohorts. All functioning scales used in the included studies (HSRS, GAS
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Table 2. Rate of Remission from BPD Across Five Cohorts Representing 585 Participants.
Cohort

Sources

Remission Rates
Sample Size

Remission Proportion

Follow-up in Years

1

[38]

27

33.3%

4–7

2

[45, 47]

88

52.6%

7

3

[6, 43]

64

92.2%

27

4

[46]

175

85%

10

5

[8, 44, 49]

231

99%

16

doi:10.1371/journal.pone.0160515.t002

and GAF) are revisions of the HSRS. Due to similarities across the scales, all ratings of functioning were pooled together to be representative of all included studies in the review. Overall,
the findings indicate that despite substantial increases in functioning in patients with BPD, this
level of functioning is still indicative of ongoing difficulties.
Baseline functioning ratings were provided by three studies[9, 44, 46], representing 519
patients. Aggregated baseline functioning ratings resulted in an average score of 42
(range = 35–53), indicating that patients experienced serious symptoms and serious limitations
in functioning[55]. Follow-up patient functioning was rated in six studies[6, 7, 9, 42, 43, 46],
representing 679 patients. Despite differences in the length of follow-up, the average length of
follow-up was 16 years (range = 10–27 years). Aggregated functioning scores at follow-up
resulted in an average score of 63 (range = 57–67). Patients were considered functioning well,
however experienced mild symptoms and continuing difficulties with vocational functioning
[55]. The change between baseline (42) and follow-up (63) functioning scores was substantial
[56].
Predictors of outcomes. Seven studies examined variables that were predictive of outcomes[39, 40, 43, 45–48]. Being diagnosed at a younger age, without experiences of childhood
sexual abuse or a family history of substance abuse predicted a faster rate of recovery[48]. This
was exemplified by findings that suggest familial experiences, such as substance abuse, history
of mental illness and divorce, were predictive of negative outcomes[39, 40]. Discrepancies however arose over the protective ability of being diagnosed at a younger age and having higher levels of educational attainment and intelligence, as these were not replicated across studies[39,
40, 43, 46].
Illness manifestation variables were identified to be the strongest predictors of global outcomes in patients with BPD, however discrepancies in the predictive ability of the illness
course, admission index, demographic and background variables were identified. Meeting
Gunderson and Kolb’s[50] criteria for BPD, experiencing personality disorder traits or affective
symptomatology with dysphoric features was associated with poorer outcomes, however lower
levels of psychosocial stress was a protective factor[39, 43]. Clinical indicators of faster rates of
remission were associated with personality traits including low neuroticism, high agreeableness
and the absence of anxious cluster personality disorders[48]. Hospitalisations were predictive
Table 3. Rate of Recurrence from BPD Across Two Cohorts Representing 406 Participants.
Cohort

Sources

Recurrence Rates
Sample size

Recurrence Proportion

Follow-Up in Years

4

[46]

175

• 21% (following 12 months of remission)
• 11% (following of 10 years remission)

10

5

[8, 44, 49]

231

• 36% (following 2 years of remission)
• 10% (following 8 years of remission)

16

doi:10.1371/journal.pone.0160515.t003
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Table 4. Rate of Diagnosis Retainment from BPD Across Four Cohorts Representing 354 Participants.
Cohort

Sources

Diagnosis Retainment Rates
Sample size

Retainment Proportion

Follow-Up in Years

1

[38]

27

66.7%

4–7

2

[45, 47]

88

47.4%

7

3

[6, 43]

64

7.8%

27

4

[46]

175

9%

10

doi:10.1371/journal.pone.0160515.t004

of the illness course where the length of prior admissions predicted the length of future admissions[40]. However, the predictive ability of hospitalisations on outcomes was inconsistent
where some studies found that longer hospitalisations lead to poorer outcomes[39], whilst
other studies found no difference[40].
Differences between BPD and other disorders. Ten studies included in the review examined the association of BPD with other disorders. Common disorders examined included
schizophrenia (n = 4), major depressive disorder (MDD, n = 4) and other personality disorders
(n = 4). Differences in remission rates and functioning (as measured by standardised measures
including the HSRS, GAS and GAF) were identified between disorders, such that patients with
BPD had higher levels of functioning than patients with schizophrenia but not other personality disorders[9, 42]. Contradictory results with MDD were noted where some studies found
patients with BPD functioned more poorly[46] whereas others found no difference[7]. Results
examining concomitant MDD with BPD were also contradictory such that some studies found
poorer outcomes in patients with MDD and BPD compared to BPD alone[7]. Rates of remission differed between the disorders such that BPD remitted at a slower rate compared to MDD
and other personality disorders[8, 46, 49] but faster than schizophrenia[53]. This suggests that
patients with schizophrenia have poorer outcomes compared to patients with BPD; however it
is unclear as to whether patients with MDD and other personality disorders have better outcomes than patients with BPD.

Main findings from qualitative studies
Themes from the qualitative studies depicted consumer goals and factors that facilitated their
recovery, however despite the ability to identify recovery or treatment goals, the conceptualisation of recovery was questioned. The consumer perceptions of their recovery fell into three
broad themes; 1) active willingness to engage in the recovery journey, 2) improving on clinical
characteristics of BPD to facilitate change and 3) the conceptualisation of recovery.
Active willingness to engage in recovery journey. This theme was articulated across all
qualitative studies where the desire for recovery was a prerequisite for change in other recovery
dimensions[18, 22, 51]. Studies identified that active willingness was initiated through the
desire for meaningful roles, vocation and motivation to not be defeated by the disorder. Consumer engagement in a vocation or activities, such as completing daily tasks (e.g. paying bills),
education, therapy or developing a career, facilitated change and provided a sense of achievement, competence and routine[18, 22, 51].
Having a sense of defiance to being defined or defeated by the disorder was identified by
studies to promote consumer’s willingness to engage in the recovery process[51]. Gaining
greater insight into BPD, through psychoeducation and therapy, facilitated recovery through
the provision of a new language to communicate inner states and needs, in order to respond in
an emotionally regulated manner and increase consumer’s awareness of the functions of
behaviour.
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Improving on clinical characteristics of BPD to facilitate change. The ability to improve
upon three clinical characteristics of BPD: 1) emotion regulation, 2) developing a sense of identity, and 3) improving interpersonal skills and relationships, were necessary in order to engage
in other aspects of recovery.
The need for better 1) emotion regulation was reported by all studies, such that having a
greater emotional experience facilitated recovery in other areas of consumer’s lives. The ability
to tolerate intense positive and negative emotions without the urge to engage in maladaptive
behaviours was a priority. Similarly, despite the ability of self-harm to abate suicidal ideation,
the reduction of self-harming behaviours promoted personal development in areas including
identity formation and interpersonal relationships.
Developing 2) a sense of identity was an initial internal motivator for change that occurred
through the acknowledgment of past experiences, developing a sense of self separate from others, and understanding the BPD diagnosis. The process of redefining identity commenced
through a shift away from the passive and victim persona and the acceptance of past experiences to focus on the present[18, 22]. Although these were observed to reduce self-critical
thoughts and promote self-acceptance, difficulties associated with the misunderstanding and
misinterpretation of a consumer’s intention by others was observed to hinder this process[51].
For example, suicide attempts were identified as selfish and inconsiderate rather than fulfilling
an emotion regulation function[51]. Studies noted that the misinterpretations of others exacerbated the stigma perceived by consumers, perpetuating their negative perception of self, however gaining understanding into BPD provided behavioural insight and greater self-acceptance.
Furthermore, developing a sense of identity separate from others was associated with the development self-confidence[18]. The ability to express emotions and ask for needs to be met was
facilitated through the development of assertiveness and was perceived as a sign of recovery.
Strengthening 3) interpersonal skills and relationships, was identified by studies to assist in
widening a consumer’s social network and provided opportunities to translate skills from therapy[18, 22, 51]. Positive benefits included learning to tolerate feelings of abandonment and
rejection, and dealing with or ending dysfunctional relationships[18, 22]. Studies identified
that having a sense of trust was essential in developing stronger relationships with others. However, this was paradoxical as a level of trust prior to entering into a relationship was required
[18]. A trusting relationship with the health system was particularly highlighted such that
health professionals acted as an extended support network that could be drawn upon during
times of need[18, 51]. However, stigma associated with the diagnostic label hindered trust formation and a consumer’s ability to fully engage[51]. Similarly, family and friends were also
viewed to be an extended support network.
The development of interpersonal skills was noted by studies to assist in the improvement
of the reflective capacity of consumers, allowing for greater insight into the impact of one’s
behaviour on others[22]. This was identified as a particularly important skill as the ability to
empathise with others during periods of distress was diminished[51].
The conceptualisation of recovery. The conceptualisation of recovery from BPD was discussed by two of the three qualitative studies[18, 22]. Studies discussed consumer’s concerns as
to whether the word accurately encapsulated their experiences. The dichotomous understanding of recovery was identified as an issue, as consumers viewed the synonymous conceptualisation of recovery and cure as unrepresentative of their experiences with BPD. Additionally,
clinical implications were highlighted such that ‘black and white’ thinking may contribute to
delays in help seeking. Alternative conceptualisations offered by studies described consumer
experiences as a “journey”, “progress” or “learning”[18, p6]. This was particularly demonstrated within discussion about personal recovery goals where the multifaceted nature was
emphasised. Recovery goals were associated with personal development (such as developing
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greater control over emotions and negative thinking patterns), developing interpersonal relationships and participation in activities and vocation (such as day to day activities, education
or employment). Differences in the service defined understanding of recovery elicited frustration in consumers, where aspects of clinical recovery (including the reduction of symptoms)
was emphasised. For example, the emphasis on specific behavioural change in some treatments
may not always align to individual recovery goals[22]. Difficulties with emotion regulation and
interpersonal relationships were continual challenges for consumers meaning full remission
may not be achieved. Katsakou and colleagues’[22] study described consumer’s recovery in
stages from no progress to recovered.

Discussion
The review aimed to examine the clinical and personal conceptualisation of recovery from
BPD through the perspectives of consumers, clinicians, family and carers. Despite the aim,
most of the current literature to date was focused upon the clinical recovery of consumers with
BPD. Clinician and observer ratings (e.g. of functioning) and consumer ratings (e.g. of symptoms) predominated. Although research into BPD has increased, limited attention has been
placed on the lived experience of consumers and their support networks. The earliest article
examining recovery from a consumer’s perspective was published as recently in 2011 and no
articles on the recovery experiences from the perspective of clinicians, family and carers were
identified. Overall, nineteen articles met the pre-determined inclusion criteria and were thematically synthesised, where four major findings emerged from the review.

Remission, recurrence, and diagnosis retainment of BPD
Although rates of remission, recurrence and diagnosis retainment rates from BPD have been
identified across a number of longitudinal studies, significant differences in how these concepts
have been defined exist between studies. Remission rates ranged between 33–99%, whilst recurrence and retainment rates ranged between 10–36% and 7.8–66.7% respectively. Due to large
variability within these rates, it is difficult to identify the exact proportion of patients who will
experience remission, recurrence or diagnosis retainment in any given time period because of
the use of various methodologies. These differences include; 1) the diagnostic tool used, 2)
length of follow-up, 3) patient drop-out rate, 4) methods used to locate patients at follow up,
and 5) the setting in which patients were recruited (inpatient or outpatient).
Differing cut-off requirements influences the proportion of patients that are considered
remitted, experience recurrence, or those retaining the diagnosis. Patients in two cohorts[38,
45, 47] were assessed using the DIB however differed in cut-off requirements. Pope and colleagues’[38] study endorsed a lower cut-off requirement (6 points) which may partially explain
lower rates of remission and higher rates of diagnosis retainment within the cohort, compared
to a relatively higher remission (7 point cut off requirement) and lower retainment rates found
in Links and colleagues’[45, 47] cohort. The Pope and colleagues’ study[38] was also of severe
multi-diagnostic cases seen before the first randomised controlled studies of treatment for BPD
had been published.
The time period in which patients are followed up should also be considered, which in this
review spanned between 4 and 27 years. Cohorts with longer follow-up periods, that is greater
than 10 years[6, 8, 43, 44, 46, 49], have higher rates of remission, indicating that the experience
of symptoms reduce with increasing age. This may be partially explained by previous research
which has suggested that the experience of impulsivity in BPD reduces with increasing age[57],
whilst other reasons proposed in the literature have included the effects of social learning over
time and the avoidance of intimate relationships[58]. The stability of the disorder has been
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highlighted in other studies, such that BPD criteria followed a similar reduction trend[46]. Variability within recurrence rates was also associated with the time period as defined by researchers, where rates ranged between 10–36%[8, 44, 46, 49]. As expected, higher rates of recurrence
(21–36%) were observed following shorter periods of remission (one to two years) and lower
rates of recurrence (10–11%) following extended periods (8–10 years) of remission. Despite
recurrence only being examined in two cohorts, these findings are low and clinically promising,
suggesting that once a state of symptomatic remission is achieved, the likelihood of recurrence
is low.
High drop-out rates of greater than 20% at follow-up may have led to the overestimation of
the remission rate in three cohorts, resulting from being lost to follow-up, refusal to participate,
suicide or death by natural causes[6, 43, 45–47]. Despite this, all studies engaged in a similar
method of locating patients at follow-up (contacting patients via mail, phone or their therapists) and may favour individuals who are less engaged in vocation or have lower levels of functioning as they continued in treatment.
The variability in retainment rates appeared to be influenced by the range of follow-up
years and where patients were recruited. Shorter follow-up periods were associated with a
higher diagnosis retainment rate, however this was not observed within the cohort from Gunderson and colleagues’ study[46]. The low retainment rate (9%) following 10 years of follow-up
identified is an interesting yet promising finding compared to the higher figures identified by
other cohorts[38, 45, 47]. This however may be explained by the greater proportion of outpatients included in Gunderson and colleagues’[46] study compared to other cohorts which have
only included an inpatient sample[38, 45, 47]. Differences between individuals initially treated
within an inpatient or outpatient setting have not been examined within longitudinal studies,
although it may be assumed that individuals in outpatient settings are less symptomatic compared to those within inpatient settings. Recent treatment guidelines endorse the treatment of
individuals with BPD best occurs within the community[14, 15], thus further investigation is
required.

Greater Understanding of Personal Recovery in BPD is Required
The strong focus in the literature on clinical remission, rather than personal recovery, is not a
surprising finding, given the severity of the disorder and the significant impact BPD can have
on quality of life. This coincides with the increasing number of psychotherapeutic interventions designed specifically for the treatment of BPD. A focus on improving clinical characteristics of BPD to facilitate change was identified within qualitative studies. Although only one
study[22] identified specific treatments engaged in by participants, all qualitative studies
included treatment seeking participants. Thus, themes reported in qualitative studies may be to
a degree influenced by the theoretical orientation of treatments received. The alignment of
treatment targets with personal recovery goals however, requires further investigation where
discrepancies were identified in some studies. Katsakou and colleagues[22] identified that psychotherapeutic interventions did not address all treatment goals consumers had for recovery.
Hence, it is suggested that the target goals of specific interventions designed for the treatment
of BPD may not fully reflect the treatment goals of consumers. Developing insight into consumer goals and whether they are aligned to the goals predetermined by researchers will assist
to understanding whether interventions need to be adapted to better accommodate consumers
throughout treatment and assist in developing mental health services that are recovery-oriented. Findings of the current review suggest that functioning of consumers with BPD improve
over an extended period of time. However, the average level of functioning indicates that consumers have ongoing difficulties with functioning, with approximately 65% of consumers not
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engaged in a vocation during the follow-up period. This is consistent with previous research
examining vocational functioning in individuals with BPD[59], however research has noted
higher rates of psychosocial functioning is observed compared to vocational functioning[49,
59]. Although low rates of vocational engagement were identified in the review, qualitative
studies identified a strong desire from consumers for meaningful roles and employment, suggesting that despite intentions, symptomatic remission may not be sufficient to allow consumers engage in their desired level of vocation.
The desire for vocational engagement however, was not identified as the only facilitator of
recovery where the completion of day to day activities contributed to a consumer’s willingness
to engage in the recovery process. This not only exemplifies the personalised nature of recovery
journey but also indicates that the stage of recovery may influence a consumer’s perceived ability to engage in vocation and activities. To strengthen the level of societal participation, recommendations for the integration of psychiatric rehabilitation as part of the treatment of BPD
have been suggested in the literature[49, 59, 60]. However, little is known about the stages of
recovery from BPD and whether differing recovery stages require adapted approaches to better
suit the consumer. Greater consideration of the association between a consumer’s self-rated
stage of recovery and their narratives may provide insight into the needs of individuals at different stages of recovery and also how psychiatric rehabilitation services can incorporate this
into care.

Consumer Conceptualisations of Recovery Requires Further
Investigation
Findings from the qualitative studies indicate that the word ‘recovery’ may not fully encapsulate the experiences of consumers with BPD. Two papers included in the review[18, 22] discuss
the concerns of consumers; however do not propose a more holistic conceptualisation. This is
a unique finding as previous research examining recovery in other mental illnesses has readily
used the term to describe the consumer experience[61, 62].
The shift away from understanding recovery purely from a clinical perspective was
highlighted in both longitudinal and qualitative studies, where symptom management and
reduction was not identified as a consumer’s highest priority. The engagement in vocation and
activities was prioritised by consumers, further suggesting that clinically focused conceptualisations of recovery may not describe the recovery experience. This also reflects differences
between the definition of clinical and personal recovery and indicates that these notions of
recovery may be interconnected. This is consistent with suggestions that clinical and personal
recovery is complementary of each other[4, 62]. Although a number of conceptual frameworks
describing personal recovery have been posited in the literature (see [17, 63] for review), limited research in the literature has examined how clinical recovery fits into the conceptual
frameworks of recovery.
Conceptualising recovery in light of consumer views may be a more holistic approach to
understanding outcomes in BPD. This can include shifting away from solely focusing upon the
acute clinical symptoms by incorporating individualised assessments in determining outcomes.
Gaining understanding of consumer goals for treatment and recovery and incorporating their
views into clinical practice and psychotherapy research may assist to personalise interventions
to suit individual consumers.

Perspectives of Family and Carers are Needed in the Literature
At present, no studies have examined the perspectives of family and carers on recovery. Considering the increased caring role family and carers have taken on since the
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deinstitutionalisation of mental health services overcoming this limitation is important, especially given the burden of caring reported in recent work[64–67]. Differences between carers
and consumers over the factors attributed to recovery have also emerged[68], however these
perspectives have not been specifically applied to BPD and limited understanding into the
actions or strategies adopted by family and carers to promote recovery in their loved ones on a
day to day basis have been examined in the literature. Understanding the facilitators and hindrances associated with recovery through multiple perspectives may lead to the strengthening
or adaptation of actions and strategies to facilitate recovery.
Similarly the perspectives of mental health clinicians on the recovery journey in BPD were
also absent. Misunderstandings surrounding what constitutes as recovery has also been identified as a barrier to clinicians promoting recovery[69]. Differences in understanding may have
detrimental effects on therapeutic alliance. Gaining a clear understanding into how clinicians
perceive recovery and whether these perceptions align to consumers’ perspectives may assist
with strengthening the therapeutic alliance.

Strengths and Limitations of the Review
Although only one researcher screened and assessed articles for review inclusion, the greater
focus on the clinical aspects of recovery in BPD identified by the systematic search limits has
the capacity to provide a balanced review of this area. The absence of studies meant a holistic
view of the recovery process from the perspectives of consumers can only be gleaned from
what is available. Despite similarities in the diagnostic criterion used (eg DIB, DSM-III,
DSM-IV and Gunderson & Kolb’s[50] criteria), each criteria have different definitions for
what is considered remission or relapse. Skewed results may result and these differences may
have an impact upon understanding patient outcomes between studies.
The exclusion of the forensic settings from this study may have had the effect of reducing
the opportunity to include males with BPD in this review, since it is known that such settings
have a high proportion of males with BPD. The specific impact of incarceration or other forensic involvement on recovery from BPD is unknown. We recommend that future studies specifically study this group, in order to progress our understanding of recovery from those who have
the disorder. Such work may also help to understand the effect on BPD recovery from varying
rates and durations of incarceration or involvement in the criminal justice system.
The review excluded studies with a follow-up period of less than five years and all intervention related studies. This resulted in the exclusion of studies examining the effectiveness of
treatments, as these would provide a description of the treatment effects and mechanisms driving change rather than long-term outcomes. The types of treatments received by consumers
however, may influence the factors associated with recovery identified from both the longitudinal and qualitative studies. Future research could identify whether a relationship between the
types of psychotherapeutic interventions received with the types of treatment goals consumers
have for recovery.

Conclusion
Despite increasing evidence that symptomatic remission from BPD is possible, the focus on
traditional understandings of recovery has been questioned by consumers, where a more holistic approach has been called for. It may be that a better understanding of recovery includes
maintaining sub-threshold symptom expression, engaging in vocational activities that are personally meaningful, and sustaining close personal relationships. Further research is needed to
define personal definitions of recovery from BPD. This is in contrast to traditional notions of
recovery (as absence of symptoms) and acknowledges that difficulties in functioning may
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persist, as noted by findings reviewed here. Additionally, the increasing role of a consumer’s
support network in contributing to their recovery has been acknowledged, however this has
not translated into the research literature. Understanding of the views, perspectives and difficulties clinicians and family and carers may have towards recovery in BPD will assist in understanding interactions between these groups and to identify implications for comprehensive
treatment.

Supporting Information
S1 Table. PRISMA checklist.
(DOCX)
S2 Table. Quality assessment of quantitative studies using Lupppino and colleagues[29]
criteria.
(DOCX)
S3 Table. Quality assessment of qualitative studies using Kuper, Lingard and Levison[32]
and Daly and colleagues’ heirarchy of evidence[33].
(DOCX)

Author Contributions
Conceptualization: FYYN MEB BFSG.
Data curation: FYYN.
Formal analysis: FYYN.
Funding acquisition: FYYN MEB BFSG.
Investigation: FYYN MEB BFSG.
Methodology: FYYN BFSG.
Project administration: FYYN.
Resources: FYYN MEB BFSG.
Supervision: MEB BFSG.
Validation: FYYN MEB BFSG.
Visualization: FYYN MEB BFSG.
Writing - original draft: FYYN.
Writing - review & editing: FYYN MEB BFSG.

References
1.

Jacobson N, & Greenley D. What is Recovery? A Conceptual Model and Explication. Psychiatric Services. 2001; 52(4):482–485. doi: 10.1176/appi.ps.52.4.482 PMID: 11274493

2.

Whitley R, & Drake RE. Recovery: A dimensional approach. Psychiatric Services. 2010; 61(12):1248–
1250. doi: 10.1176/ps.2010.61.12.1248 PMID: 21123410

3.

Davidson L, & Roe D. Recovery from versus recovery in serious mental illness: One strategy for lessening confusion plaguing recovery. Journal of Mental Health. 2007; 16(4):459–470. doi: 10.1080/
09638230701482394

4.

Slade M. Personal Recovery and Mental Illness: A Guide for Mental Health Professionals. New York:
Cambridge University Press; 2009.

PLOS ONE | DOI:10.1371/journal.pone.0160515 August 9, 2016

18 / 21

Recovery from Borderline Personality Disorder

5.

Le Boutillier C, Chevalier A, Lawrence V, Leamy M, Bird VJ, Macpherson R, et al. Staff understanding
of recovery-oriented mental health practice: A systematic review and narrative synthesis. Implementation Science. 2015; 10(87). doi: 10.1186/s13012-015-0275-4

6.

Paris J, & Zweig-Frank H. A 27-year follow up of patients with borderline personality disorder. Comprehensive Psychiatry. 2001; 42(6):482–487. doi: 10.1053/comp.2001.26271 PMID: 11704940

7.

McGlashan TH. The Chestnut Lodge Follow-Up Study III Long Term Outcome of Borderline Personalities. Archives of General Psychiatry. 1986; 43(1):20–30. doi: 10.1001/archpsyc.1986.
01800010022003 PMID: 3942471

8.

Zanarini MC, Frankenburg FR, Reich B, & Fitzmaurice G. Attainment and stability of sustained symptomatic remission and recovery among borderline patients and axis II comparison subjects: A 16-year
prospective follow-up study. American Journal of Psychiatry. 2012; 169(5):476–483. doi: 10.1176/appi.
ajp.2011.11101550 PMID: 22737693

9.

Plakun EM, Burkhardt PE, & Muller JP. 14-year follow up of borderline and schizotypal personality disorder. Comprehensive Psychiatry. 1985; 26(5):448–455. doi: 10.1016/0010-440X(85)90081-1 PMID:
4028695

10.

Bateman AW, Gunderson J, & Mulder R. Treatment of Personality Disorder. The Lancet. 2015;
385:735–743. doi: 10.1016/S0140-6736(14)61394-5

11.

Chanen A. Borderline personality disorder in young people: Are we there yet? Journal of Clinical Psychology. 2015:Advance online publication. doi: 10.1002/jclp.22205

12.

Leichsenring F, Leibing E, Kruse J, New AS, & Leweke F. Borderline Personality Disorder. Lancet.
2011; 377:74–84. doi: 10.1016/S0140-6736(10)61422-5 PMID: 21195251

13.

McMain SF, Links PS, Gnam WJ, Guimond T, Cardish RJ. Korman L, et al. A randomized trial of dialectical behavioural therapy versus general psychiatric managment for borderline personality disorder.
American Journal of Psychiatry. 2009; 166(12):1365–1374. doi: 10.1176/appi.ajp.2009.09010039
PMID: 19755574

14.

National Institute for Health and Care Excellence. Borderline Personality Disorder: Treatment and Management. 2009.

15.

National Health and Medical Research Council. Clinical Practice Guideline for the Management of Borderline Personality Disorder. Melbourne: National Health and Medical Research Council, 2012.

16.

Anthony WA. Recovery from mental illness: The guiding vision of the mental health service system in
the 1990s. Psychosocial Rehabilitation Jounral. 1993; 16(4):521–537. doi: 10.1037/h0095655

17.

Leamy M, Bird V, Le Boutillier C, Williams J, & Slade M. Conceptual Framework for Personal Recovery
in Mental Health: Systematic Review and Narrative Synthesis. The British Journal of Psychiatry. 2011;
199:445–452. doi: 10.1192/bjp.bp.110.083733 PMID: 22130746

18.

Lariviere N, Couture E, Blackburn C, Carbonneau M, Lacombe C, Schinck SA, et al. Recovery, as
experienced by women with borderline personality disorder. Psychiatric Quarterly 2015:Advance online
publication. doi: 10.1007/s11126-015-9350-x

19.

Horn N, Johnstone L, & Brooke S. Some service user perspectives on the diagnosis of borderline personality disorder. Journal of Mental Health. 2007; 16(2):255–269. doi: 10.1080/09638230601056371

20.

Nehls N. Borderline personality disorder: The voice of patients. Research in Nursing and Health. 1999;
22:285–293. doi: 10.1002/(SICI)1098-240X(199908)22:4<285::AID-NUR3>3.0.CO;2-R PMID:
10435546

21.

Straker G, & Waks B. Limit setting in regard to self-damaging acts: The patient's perspective. Psychotherapy. 1997; 34(2):192–200. doi: 10.1037/h0087846

22.

Katsakou C, Marougka S, Barnicot K, Savil M, White H, Lockwood K et al. Recovery in borderline personality disorder (BPD): A qualitative study of service users' perspectives. Plos One. 2012; 7(5):
e36517. doi: 10.1371/journal.pone.0036517 PMID: 22615776

23.

Nehls N. What is a case manager? The perspectives of persons with borderline personality disorder.
Journal of the American Psychiatric Nurses Association. 2001; 7(1):4–12. doi: 10.1067/mpn.2001.
113132

24.

Perseius KI, Ojehagen A, Ekdahl S, Asberg M, & Samuelsson M. Treatment of suicidal and deliberate
self-harming patients with borderline personality disorder using dialectical behavioural therapy: The
patients' and the therapists' perceptions. Archives of Psychiatric Nursing. 2003; 17(5):218–227. doi: 10.
1053/S0883-9417(03)00093-1 PMID: 14608551

25.

Briand-Malenfant R, Lecours S, & Deschenaux E. What does sadness mean to BPD patients? Journal
of Personality Disorders. 2012; 26(6):939–955. doi: 10.1521/pedi.2012.26.6.939 PMID: 23281678

26.

Miller SG. Borderline personality disorder from the patient's perspective. Hospital and Community Psychiatry. 1994; 54(12):1215–1219. doi: 10.1176/ps.45.12.1215

PLOS ONE | DOI:10.1371/journal.pone.0160515 August 9, 2016

19 / 21

Recovery from Borderline Personality Disorder

27.

Moher D, Liberati A, Tetzlaff J, Altman DG, & The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. Annals of Internal Medicine. 2009; 151
(4):264–269. doi: 10.7326/0003-4819-151-4-200908180-00135 PMID: 19622511

28.

Kuijpers T, van der Windt DAWN, van der Heijden GJMG, & Bouter LM. Systematic review of prognostic cohort studies on shoulder disorders. Pain. 2004; 109(3):420–431. doi: 10.1016/j.pain.2004.02.017
PMID: 15157703

29.

Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BWJH, et al. Overweight, Obesity
and Depression: A Systematic Review and Meta-Analysis of Longitudinal Studies. Archives of General
Psychiatry. 2010; 67(3):220–229. doi: 10.1001/archgenpsychiatry.2010.2 PMID: 20194822

30.

DiSipio T, Rye S, Newman B & Hayes S. Incidence of unilateral arm lymphoedema after breast cancer:
A systematic review and meta-analysis. Lancet Oncology. 2013; 14(6):500–515. doi: 10.1016/S14702045(13)70076-7 PMID: 23540561

31.

Mols F, Vingerhoets AJJM, Coebergh JW, & van de Poll-Franse LV. Quality of life among long-term
breast cancer survivors: A systematic review. European Journal of Cancer. 2005; 41(17):2613–2619.
doi: 10.1016/j.ejca.2005.05.017 PMID: 16226458

32.

Kuper A, Lingard L., & Levinson W. Critically appraising qualitative research. British Medical Journal.
2008; 337:687–689. doi: 10.1136/bmj.a1035

33.

Daly J, Willis K, Small R, Green J, Welch N, Kealy M, et al. A hierarchy of evidence for assessing qualitative health research. Journal of Clinical Epidemiology. 2007; 60(1):43–49. doi: 10.1016/j.jclinepi.
2006.03.014 PMID: 17161753

34.

Siabani S, Leeder SR, & Davidson PM. Barriers and facilitators to self-care in chronic heart failure: A
meta-synthesis of qualitative studies. Springer Plus. 2013; 2(1):320–334.

35.

Stack RJ, Sahni M, Mallen CD, & Raza K. Symptom complexes at the earliest phases of rheumatoid
arthritis: A synthesis of the qualitative literature. Arthritis Care and Research. 2013; 65(12):1916–1926.
doi: 10.1002/acr.22097 PMID: 23926091

36.

Swennen MHJ, van der Heijden GJMG, Boeije HR, van Rheenen N, Verheul FJM, van der Graaf Y,
et al. Doctors' perceptions and use of evidence-based medicine: A systematic review and thematic synthesis of qualitative studies. Academic Medicine. 2013; 88(9):1384–1396. doi: 10.1097/ACM.
0b013e31829ed3cc PMID: 23887011

37.

Thomas J, & Harden A. Methods for the thematic synthesis of qualitative resarch in systematic reviews.
BMC Medical Research Methodology. 2008; 8(45):1–10. doi: 10.1186/1471-2288-8-45

38.

Pope HG, Jonas JM, Hudson JI, Cohen BM, & Gunderson JG. The validity of DSM-III borderline personality disorder. Archives of General Psychiatry. 1983; 40:23–30. doi: 10.1001/archpsyc.1983.
01790010025003 PMID: 6849616

39.

McGlashan TH. The Prediction of Outcome in Borderline Personality Disorder: Part V of the Chestnut
Lodge Follow-Up Study. In: McGlashan TH, editor. The Borderline: Current Empirical Research. 1:
American Psychiatric Publication Incorporated; 1985. p. 61–98.

40.

Plakun EM. Prediction of Outcome in Borderline Personality Disorder. Journal of Personality Disorders.
1991; 5(2):93–101. doi: 10.1521/pedi.1991.5.2.93

41.

Stone MH. The Fate of Borderline Patients. New York: The Guilford Press; 1990.

42.

Stone MH, Hurt SW, & Stone DK. The PI 500: Long-term follow up of borderline inpatients meeting
DSM-III criteria I. Global outcome. Journal of Personality Disorders. 1987; 1(4):291–298. doi: 10.1521/
pedi.1987.1.4.291

43.

Paris J, Brown R, & Nowlis D. Long-term Follow-up of Borderline Patients in a General Hospital. Comprehensive Psychiatry. 1987; 28(6):530–535. doi: 10.1016/0010-440X(87)90019-8 PMID: 3691077

44.

Zanarini MC, Frankenburg FR, Hennen J, & Silk KR. The longitudinal course of borderline psychopathology: 6 year prospective follow-up of the phenomenology of borderline personality disorder. American Journal of Psychiatry. 2003; 160(2):274–283. doi: 10.1176/appi.ajp.160.2.274 PMID: 12562573

45.

Links PS, Heslegrave RJ, Mitton JE, Van Reekum R, & Patrick J. Borderline psychopathology and
recurences of clinical disorders. The Journal of Nervous and Mental Disease. 1995; 183(9):582–586.
0022-3018/95/1839-052$03.00/0. PMID: 7561820

46.

Gunderson JG, Stout RL, McGlashan T, Shea T, Morey LC, Grilo CM, et al. Ten-Year Course of Borderline Personality Disorder. Archives of General Psychiatry. 2011; 68(8):827–837. doi: 10.1001/
archgenpsychiatry.2011.37 PMID: 21464343

47.

Links PS, Heslegrave R, & Van Reekum R. Prospective follow-up study of borderline personality disorder: Prognosis, prediction of outcome, and axis II comorbidity. Canadian Journal of Psychiatry. 1998;
43(3):265–270. PMID: 9561315

PLOS ONE | DOI:10.1371/journal.pone.0160515 August 9, 2016

20 / 21

Recovery from Borderline Personality Disorder

48.

Zanarini MC, Frankenberg FR, Hennen J, Reich DB, & Silk KR. Prediction of the 10-Year Course of
Borderline Personality Disorder. American Journal of Psychiatry. 2006; 163:827–832. doi: 10.1176/ajp.
2006.163.5.827 PMID: 16648323

49.

Zanarini MC, Frankenburg FR, Reich DB, & Fitzmaurice G. Time to attainment of recovery from borderline personality disorder and stability of recovery: A 10-year prospective follow-up study. American
Journal of Psychiatry. 2010; 167(6):663–667. doi: 10.1176/appi.ajp.2009.09081130 PMID: 20395399

50.

Gunderson JG, & Kolb JE. Discriminating features of borderline patients. The American Journal of Psychiatry. 1978; 135(7):792–796. PMID: 665789

51.

Holm AL, & Severinsson E. Struggling to recover by changing suicidal behaviour: Narratives from
women with borderline personality disorder. International Journal of Mental Health Nursing. 2011;
20:165–173. doi: 10.1111/j.1447-0349.2010.00713.x PMID: 21492357

52.

Feighner JP, Robins E, Guze SB, Woodruff RA, Winokur G, & Munoz R. Diagnostic Criteria for Use in
Psychiatric Research. Archives of General Psychiatry. 1972; 26(1):57–63. doi: 10.1001/archpsyc.
1972.01750190059011 PMID: 5009428

53.

McGlashan TH. The Chestnut Lodge follow-up study II. Long term outcomes of schizophrenia and the
affective disorders. Archives of General Psychiatry. 1984; 41(6):586–601. doi: 10.1001/archpsyc.1984.
01790170060007 PMID: 6732419

54.

Kernberg OF. Object Relation Theory and Clinical Psychoanalysis. Northvale, NJ: Aronson; 1976.

55.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Text
Revision ed. Washington DC: American Psychiatric Association; 2000.

56.

Endicott J, Spitzer RL, Fleiss JL, & Cohen J. The Global Assessment Scale: A Procedure for Measuring
Overall Severity of Psychiatric Disturbance. Archives of General Psychiatry. 1976; 33(6):766–771.
PMID: 938196

57.

Stevenson J, Meares R, & Comerford A. Diminished impulsivity in older patients with borderline personality disorder. American Journal of Psychiatry. 2003; 160(1):165–166. doi: 10.1176/appi.ajp.160.1.165
PMID: 12505816

58.

Paris J. Implications of long-term outcome research for the management of patients with borderline personality disorder. Harvard Review of Psychiatry. 2002; 10(6):315–320. doi: 10.1080/10673220216229
PMID: 12485978

59.

Skodol AE, Gunderson JG, McGlashan TH, Dyck IR, Stout RL, Bender DS, et al. Functional impairments in patients with schizotypal, borderline, avoidant or obsessive-compulsive personality disorder.
American Journal of Psychiatry. 2002; 159:276–283. doi: 10.1176/appi.ajp.159.2.276 PMID: 11823271

60.

Weinberg I, Ronningstam E, Goldblatt MJ, Schechter M, & Maltsberger JT. Common Factors in Empirically Supported Treatments of Borderline Personality Disorder. Current Psychiatry Reports. 2011;
13:60–68. doi: 10.1007/s11920-010-0167-x PMID: 21057901

61.

Deegan PE. Recovery: The lived experience of rehabilitaion. Psychosocial Rehabilitation Jounral.
1988; 11(4):11–19. doi: 10.1037/h0099565

62.

Davidson L, Lawless MS, & Leary F. Concepts of recovery: competing or complementary? Current
Opinion in Psychiatry. 2005; 18(6):664–667. PMID: 16639093

63.

Andresen R, Oades L, & Caputi P. The experience of recovery from schizophrenia: Towards an empirically validated stage model. Australian and New Zealand Journal of Psychiatry. 2003; 37:586–594. doi:
10.1046/j.1440-1614.2003.01234.x PMID: 14511087

64.

Bailey RC, & Grenyer BFS. Burden and Support Needs of Carers of Persons with Borderline Personality Disorder: A Systematic Review. Harvard Review of Psychiatry. 2013; 21(5):248–258. doi: 10.1097/
HRP.0b013e3182a75c2c PMID: 24651557

65.

Bailey RC, & Grenyer BFS. Supporting a Person with Personality Disorder: A Study of Carer Burden
and Well-being. Journal of Personality Disorders. 2014; 28:796–809. doi: 10.1521/pedi_2014_28_136
PMID: 24689763

66.

Dunne E, & Rogers B. "It's us that have to deal with it seven days a week": Carers and borderline personality disorder. Community Mental Health Journal. 2013; 49(6):643–648. doi: 10.1007/s10597-0129556-4 PMID: 23054157

67.

Giffin J. Family Experience of Borderline Personality Disorder. Australian and New Zealand Journal of
Family Therapy. 2008; 29(3):133–138. doi: 10.1375/anft.29.3.133

68.

Noiseux S, Tribble St-Cry D, Corin E, St-Hilaire PL, Morissette R, Leclerc C, et al. The proecess of
recovery of people with mental illness: The perspectives of patients, family members and carer providers: Part 1. BMC Health Services Research. 2010; 10(1):161–175. doi: 10.1186/1472-6963-10-161

69.

Rogers B, & Dunne E. A qualitative study on the use of the care programme approach with individuals
with borderline personality disorder. Journal of Psychosocial Nursing. 2013; 51(10):39–45. doi: 10.
3928/02793695-20130628-03

PLOS ONE | DOI:10.1371/journal.pone.0160515 August 9, 2016

21 / 21

